Protective effect of endoplasmic reticulum stress inhibition on 5-fluorouracil-induced oral mucositis

Eur J Pharmacol. 2022 Mar 15:919:174810. doi: 10.1016/j.ejphar.2022.174810. Epub 2022 Feb 10.

Abstract

5-Fluorouracil (5-FU)-induced oral mucositis has a severe negative impact on the patient's quality of life. This study aimed to investigate the role of endoplasmic reticulum stress (ERS) in the occurrence of 5-FU-induced oral mucositis in vivo and in the clinic. In vivo, 5-FU-induced oral mucositis model mice showed a higher level of glucose-regulated protein 78 kD (GRP78, a marker of ERS) than control mice. The inhibition of ERS could effectively reduce 5-FU-induced oxidative stress, inflammatory factor mRNA and cell apoptosis. Moreover, inhibition of ERS significantly decreased the activation of nuclear factor kappa-B (NF-κB) in 5-FU-induced oral mucositis model mice following tissue damage reduction. In the clinic, 5-FU could increase cell apoptosis and cause oral mucosa damage while increasing the expression of the ERS marker genes GRP78 and C/EBP-homologous protein (CHOP). Our study found that 5-FU could induce severe ERS, upregulate the expression of GRP78 and CHOP, raise oxidative stress and increase the expression of inflammatory factors by activating the NF-κB pathway, thus causing cell apoptosis and finally leading to oral mucosal injury.

Keywords: 5-fluorouracil; Chemotherapy-induced oral mucositis; Endoplasmic reticulum stress; NF-κB.

MeSH terms

  • Animals
  • Antineoplastic Agents / adverse effects
  • Disease Models, Animal
  • Endoplasmic Reticulum Stress / drug effects*
  • Fluorouracil / adverse effects
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Oxidative Stress / drug effects
  • Phenylbutyrates / administration & dosage
  • Phenylbutyrates / pharmacology*
  • Phenylbutyrates / therapeutic use
  • Stomatitis / chemically induced
  • Stomatitis / prevention & control*

Substances

  • Antineoplastic Agents
  • Phenylbutyrates
  • 4-phenylbutyric acid
  • Fluorouracil